Efficacy and Safety of Ribociclib in Pre- and Postmenopausal Chinese Women With HR Positive, HER2-negative, Advanced Breast Cancer.
Condition: Breast Cancer Interventions: Drug: Ribociclib Placebo; Drug: Ribociclib; Drug: NSAI: Letrozole or Anastrazole; Drug: Letrozole; Drug: Goserelin Sponsor: Novartis Pharmaceuticals Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials